Kurumun Atıf Alan Makalesi
Atıf Alan Yayın
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders
Scopus
Toplam 261 atıf DOI
Background Primary immunodeficiency diseases (PIDDs) are clinically and genetically heterogeneous disorders thus far associated with mutations in more than 300 genes. The clinical phenotypes derived from distinct genotypes can overlap. Genetic etiology can be a prognostic indicator of disease severity and can influence treatment decisions. Objective We sought to investigate the ability of whole-exome screening methods to detect disease-causing variants in patients with PIDDs. Methods Patients with PIDDs from 278 families from 22 countries were investigated by using whole-exome sequencing. Computational copy number variant (CNV) prediction pipelines and an exome-tiling chromosomal microarray were also applied to identify intragenic CNVs. Analytic approaches initially focused on 475 known or candidate PIDD genes but were nonexclusive and further tailored based on clinical data, family history, and immunophenotyping. Results A likely molecular diagnosis was achieved in 110 (40%) unrelated probands. Clinical diagnosis was revised in about half (60/110) and management was directly altered in nearly a quarter (26/110) of families based on molecular findings. Twelve PIDD-causing CNVs were detected, including 7 smaller than 30 Kb that would not have been detected with conventional diagnostic CNV arrays. Conclusion This high-throughput genomic approach enabled detection of disease-related variants in unexpected genes; permitted detection of low-grade constitutional, somatic, and revertant mosaicism; and provided evidence of a mutational burden in mixed PIDD immunophenotypes.
Atıf Kaynağı
Atıf Yapan Yayın
Approach to genetic diagnosis of inborn errors of immunity through next-generation sequencing
Scopus
Havuzumuzda 16 atıf almış
Patients with inborn errors of immunity (IEI) present with a heterogeneous clinical and immunological phenotype, therefore a correct molecular diagnosis is crucial for the classification and subsequent therapeutic management. On the other hand, IEI are a group of rare congenital diseases with highly diverse features and, in most cases, an as yet unknown genetic etiology. Next generation sequencing has facilitated genetic examinations of rare inherited disorders during the recent years, thus allowing a suitable molecular diagnosis in the IEI patients. This review aimed to investigate the current findings about these techniques in the field of IEI, suggesting an efficient stepwise approach to molecular diagnosis of inborn errors of immunity.
Atıf Yapan Makale Bilgileri
Kurumlar (11)
Alborz University of Medical Sciences
Karaj, Iran
Alborz University of Medical Sciences, Non-communicable Diseases Research Center
Azimiyeh, Iran
Institute of Immunohaematology Mumbai
Mumbai, India
Instituto Nacional de Pediatría
Mexico, Mexico
Karolinska Institutet
Stockholm, Sweden
Karolinska Universitetssjukhuset
Stockholm, Sweden
Research Center for Immunodeficiencies
Tehran, Iran
School of Advanced Technologies in Medicine
Tehran, Iran
Selçuk Tip Fakültesi
Konya, Turkey
Southeast University
Nanjing, China